[Clinical-economic substantiation of immunocorrection therapy of Epstein-Barr viral mononucleosis in children].
Results are presented for a group of 299 patients aged 1-14 with primary Epstein--Barr viral infection. Features of the process of a infectious mononucleosis are revealed for various kinds of immunocorrection therapy. A clinical-economic estimation of the immunocorrection therapy in children with primary Epstein-Barr viral infection has been performed.
Shvedova
N M
NM
Mikhaĭlova
E V
EV
Khmilevskaia
S A
SA
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D003365:Costs and Cost Analysis; D005260:Female; D004854:Herpesvirus 4, Human; D006801:Humans; D007167:Immunotherapy / Q000191:economics* / Q000379:methods; D007223:Infant; D007244:Infectious Mononucleosis / Q000191:economics* / Q000628:therapy*; D008297:Male; D012189:Retrospective Studies; D012426:Russia